Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine, Bortezomib, and PLD in Relapsed/Refractory Multiple Myeloma
NCT01177683Phase 2Terminated
- Start
- Jul 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM). Started Jul 2010; status: terminated.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01177683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177683.